StreetAlpha
Allogene Therapeutics, Inc. · SEC Form 4

ALLO Insider Trading

From SEC Form 429 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Allogene Therapeutics, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $668K sold.

← ALLO stock page

Insiders are only selling
Bought, 12 months$00 buys · 0 insiders
Sold, 12 months$668K14 sales · 6 insiders
Net−$668Kbought minus sold
Planned sales–of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
Dec2026-01: sold $41KJan2026-02: sold $337KFeb2026-03: sold $156KMar2026-04: sold $22KAprMayJunJul2026-08: sold $63KAugSep2026-10: sold $49KOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when ALLO insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an ALLO officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every ALLO insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Oct 21, 2026Geoffrey M. ParkerCFOSale36,342$1.34$49K1,045,877Oct 23Form 4
Aug 21, 2026Earl Martin DouglasSVP, General CounselSale29,697$2.12$63K488,267Aug 25Form 4
Apr 21, 2026Annie YoshiyamaSVP, FinanceSale9,586$2.31$22K124,517Apr 23Form 4
Mar 31, 2026Benjamin Machinas BeneskiSVP, Chief Technical OfficerSale2,867$2.50$7K195,338Apr 2Form 4
Mar 16, 2026David D ChangPresident and CEOSale47,763$2.47$118K5,150,599Mar 18Form 4
Mar 16, 2026Benjamin Machinas BeneskiSVP, Chief Technical OfficerSale4,835$2.47$12K198,205Mar 18Form 4
Mar 2, 2026Benjamin Machinas BeneskiSVP, Chief Technical OfficerSale7,132$2.60$19K203,040Mar 4Form 4
Feb 2, 2026Earl Martin DouglasSVP, General CounselSale22,900$1.76$40K564,948Feb 4Form 4
Feb 2, 2026Zachary RobertsEVP of R&DSale35,700$1.77$63K581,166Feb 4Form 4
Feb 2, 2026Annie YoshiyamaSVP, FinanceSale4,167$1.72$7K130,322Feb 4Form 4
Feb 2, 2026Geoffrey M. ParkerCFOSale24,001$1.76$42K1,252,795Feb 4Form 4
Feb 2, 2026David D ChangPresident and CEOSale95,269$1.80$171K5,185,862Feb 4Form 4
Feb 2, 2026Benjamin Machinas BeneskiSVP, Chief Technical OfficerSale7,549$1.73$13K210,172Feb 4Form 4
Jan 21, 2026Zachary RobertsEVP of R&DSale26,269$1.56$41K616,866Jan 23Form 4
Nov 17, 2025Benjamin Machinas BeneskiSVP, Chief Technical OfficerSale786$1.22$959217,721Nov 19Form 4
🔒 14 more trades. Create a free account or sign in to see them all.

ALLO insider trading FAQ

Are ALLO insiders buying or selling?

Insiders are only selling over the last 12 months. 0 insiders bought $0 of ALLO on the open market in 0 trades, and 6 sold $668K in 14 trades.

When did an ALLO insider last buy shares?

There has been no open market insider purchase of ALLO in the last two years.

When did an ALLO insider last sell shares?

Geoffrey M. Parker (CFO) sold 36,342 shares for $49K on Oct 21, 2026.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice